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Summary 44 
Microbiomes associated with human skin and the oral cavity are uniquely exposed to personal care 45 
regimes. Changes in the composition and activities of the microbial communities in these 46 
environments can be utilised to promote consumer health benefits; for example by reducing the 47 
numbers, composition or activities of microbes implicated in conditions such as acne, axillary 48 
odour, dandruff and oral diseases. It is however important to ensure that innovative approaches for 49 
microbiome manipulation do not unsafely disrupt the microbiome or compromise health, and where 50 
major changes in the composition or activities of the microbiome may occur, these require 51 
evaluation to ensure that critical biological functions are unaffected. This article is based on a two-52 
day workshop held at SEAC Unilever, Bedford, United Kingdom, involving 31 specialists in 53 
microbial risk assessment, skin and oral microbiome research, microbial ecology, bioinformatics, 54 
mathematical modelling and immunology. The first day focused on understanding the potential 55 
implications of skin and oral microbiome perturbation, while approaches to characterise those 56 
perturbations were discussed during the second day. This article discusses the factors that the panel 57 
recommend are considered for personal care products that target the microbiomes of the skin and 58 
the oral cavity.  59 
 60 
INTRODUCTION 61 
 62 
The human microbiome  63 
 64 
The last two decades have seen the effective application of culture-independent methods to study 65 
the human microbiota (the microbial cells) or microbiome (the associated DNA) (1). This has led to 66 
a deeper and more comprehensive analysis of the diverse range of organisms that inhabit the body, 67 
where a substantial proportion are not readily amenable to culture (2). In the process some but 68 
certainly not all knowledge gaps have been addressed. High-throughput sequencing is currently 69 
performed using a range of platforms including Illumina and Ion Torrent, which can rapidly 70 
sequence millions of fragments of DNA in parallel (3). Hypervariable regions of the bacterial 16S 71 
rRNA genes, or whole genome DNA is targeted to analyse complex microbial communities. For 72 
16S amplicon sequencing in particular, bioinformatic analyses have been applied to cluster the 73 
generated sequences according to their similarity to define different operational taxonomic units 74 
(OTU), which are then compared to databases to reveal community composition. However, tools 75 
such as DADA2 are being increasingly used to obtain exact sequence variants (4) giving greater 76 
resolution (5). The often short sequencing reads and the large data volumes generated through NGS 77 
presents challenges and taxonomic classification and relative abundances can vary depending on the 78 
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bioinformatic pipeline used (3). Microbiome research has nevertheless identified considerably 79 
greater microbial diversity than had been previously characterised, overcoming some of the 80 
limitations of culture including issues of non-culturability. Whilst microbiome research in humans 81 
has focussed primarily on the gut, studies of the oral cavity (6-9) and skin (10-14) have facilitated 82 
the deeper understanding of these sites, which are of particular relevance to personal care. The use 83 
of personal care products can result in changes in microbiome that may be intentional or otherwise. 84 
It is however important to note that "oral microbiome" and "skin microbiome" are simplified terms 85 
referring to biogeography-dependent sets of communities where microbial composition and 86 
activities can vary markedly depending on site. 87 
 88 
The challenge of establishing causality 89 
 90 
The human microbiome provides protection against pathogenic organisms (14) and can stimulate 91 
the immune system (15, 16) and participate in the maintenance of different ecological niches 92 
present in the body (17). Fluctuations in micobiome composition may therefore perturb beneficial 93 
microbial functions with potential health implications for the host. The following section will 94 
consider some notable diseases of the skin and the oral cavity where differentiating between cause 95 
and association for microbiome composition has been challenging.  96 
Atopic dermatitis (AD) is a chronic, relapsing inflammatory condition characterised by pruritis 97 
(itchiness), wheels and flares, and in severe cases, broken, bleeding skin. A high Staphylococcus 98 
aureus load has been reported to correlate with AD flares and vice versa in clinical studies 99 
involving AD patients, where coagulase negative staphylococci (CoNS) were more abundant in 100 
healthy controls (18). Colonisation with commensal staphylococci early in life appears to be 101 
protective against the development of AD (19), and AD is also strongly associated with mutations 102 
in the barrier protein, filaggrin (20). It has therefore been hypothesised that an abnormal epidermal 103 
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environment caused by a leaky skin barrier predisposes the skin to infection by exposing 104 
environmental niches that would normally be inaccessible to S. aureus.  105 
Unravelling the role of the microbiome in dermal diseases is confounded by the physiological 106 
changes in host tissues that characterise the pathology. Acne vulgaris, for example, has been 107 
associated with overgrowth of Cutibacterium (formerly Proprionibacterium) acnes, but this 108 
association is not necessarily causal. In addition, Acne vulgaris has been potentially linked to 109 
changes in the dermal environment proposed to be driven by factors including a Western style diet, 110 
which may influence signaling in the hair follicle resulting in overproduction of sebum (21). The 111 
photodermatosis, polymorphic light eruption (PLE) that is characterised by a rash on exposure to 112 
UV light has been associated with the abnormal expression of antimicrobial peptides in the skin, 113 
(22) distinct from that seen in psoriasis or AD, suggesting a microbiota involvement. PLE is 114 
however also associated with other changes in the immune system of the skin (23) (24). The 115 
common inflammatory skin condition psoriasis has been associated with changes in the skin 116 
microbiota (25) (26) but this association is not necessarily causal because the massive systemic 117 
inflammatory response that is a feature of psoriasis may also profoundly influence the composition 118 
of the skin microbiota (as reviewed by (27)).  119 
Whilst the relationship between the oral microbiome and oral disease is arguably better understood, 120 
knowledge gaps remain. Common conditions such as dental caries, gingivitis and periodontitis are 121 
closely associated with potentially harmful changes in the composition and activities of the oral 122 
microbiota (sometimes referred to as dysbiosis) (28) (29) that have environmental triggers. The 123 
development of caries for example, is related to high intake of sugary foods and the consequent 124 
production of lactic acid by caries-associated bacteria within the oral microbiome. This in turn 125 
favours the growth of acid-tolerant, acidogenic organisms such as Streptococcus mutans which, 126 
along with other oral bacteria, forms biofilms on the tooth surface (30). Acid produced by these 127 
organisms can alter the balance of enamel demineralisation/remineralisation of the tooth, leading to 128 
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loss of mineral, and caries formation. In periodontitis, the persistent presence of subgingival 129 
biofilms associated with poor oral hygiene can lead to inflammation and bone loss (31). The 130 
pathology of periodontitis is largely caused by the host response and the primary risk factor is host 131 
susceptibility (as reviewed by Wade (32)). However, certain species of bacteria favour inflamed 132 
sites including Porphyromonas gingivalis, which can subvert the host response leading to a 133 
“dysbiotic” microbiota, which further exacerbates lesions (33). Whilst the role of the host response 134 
in periodontitis is well established, the roles of host response and microbiome for gingivitis merits 135 
further research. Additionally, some reports suggest that oral bacteria can translocate from the 136 
mouth into the systemic circulation and whilst causality has not been confirmed, periodontitis for 137 
example, has been associated with other conditions such as coronary artery disease (34), rheumatoid 138 
arthritis (35) and respiratory disease (36) (37).  139 
 140 
Targeting specific microbes with personal care products 141 
 142 
As well as investigating the role of the microorganisms present in health and disease, microbiome 143 
research is increasingly being applied to investigate the fundamental biology of various skin 144 
conditions (38), oral hygiene (39), dandruff (40), dental caries (41), acne (42) and periodontitis (28, 145 
29) (Table 1). Recent advances in this field include improved knowledge of the bacterial and fungal 146 
composition of the scalp in individuals with and without dandruff (43), and the identification of 147 
bacteria involved in axillary (44) and oral (45) malodour. In addition, the importance of bacterial 148 
strain variability in acne is also now appreciated; although the overall relative abundance of C. 149 
acnes is comparable between acne and healthy individuals, significant differences at the strain level 150 
have been observed (42). Manipulation of the compositional structure or function of skin and oral 151 
microbiomes can potentially counteract certain undesirable health conditions where use of 152 
probiotics, prebiotics and targeted antimicrobials may provide opportunities to restore the healthy 153 
microbial composition of the skin (46) and oral cavity (47) (48). Manipulating innate immunity of 154 
the skin and oral cavity is a another route through which this could be achieved (39) (49) 155 
 7 
Aims and Objectives 156 
 157 
Whilst differentiating between association and causality remains a key issue in microbiome 158 
research, the fact that in some cases interactions between the microbiome and the host play a role in 159 
health and disease has been established (as previously reviewed (50)). It is therefore important that 160 
the effect of personal care regimes on the microbiome receives adequate consideration. 161 
Understanding of the factors that cause fluctuations in the microbiome is likely to contribute to the 162 
development of novel approaches to understand potential links to undesirable health conditions, and 163 
to the identification of microbiome-based biomarkers. It is in this context that the U.S. National 164 
Academy of Sciences have discussed the need to incorporate interactions between the microbiome 165 
and chemicals in assessing human health risks associated with environmental chemical exposure 166 
(51). As understanding of the functional significance of the human microbiome progresses, and the 167 
exploration of host-microbial interactions advances, understanding the effects of intentional 168 
manipulation of the human microbiome in the context of human safety should be addressed.  169 
In October 2016, a workshop was organised at Colworth Science Park in the UK including 31 170 
specialists in the areas of microbial risk assessment, skin and the oral microbiome, microbial 171 
ecology, bioinformatics, bacterial modelling and immunology. This manuscript emerged from 172 
exploration of the areas discussed during the workshop. It considers factors that the panel agreed 173 
require consideration when evaluating the safety of personal care products that aim to benefit the 174 
consumer by affecting the composition or activities of the skin and oral microbiomes. 175 
PROTECTION OF THE ORAL AND SKIN MICROBIOME FUNCTIONS TO PROMOTE 176 
HEALTH 177 
 178 
The human microbiome in health and wellbeing 179 
 180 
Microbiotas associated with the oral mucosa and the skin help programme the human immune 181 
system to recognise pathogens (52, 53), reduce the risk of invasion by undesired organisms (54), 182 
produce vitamins and other metabolites such as short-chain fatty acids (55). In skin, Phenol Soluble 183 
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Modulins (PSMs) and bacteriocins (56) contribute to the ecological and structural maintenance of 184 
the niche (54). Commensal skin organisms such as S. epidermidis and C. acnes use distinct 185 
mechanisms to inhibit pathogens and maintain a healthy skin barrier. S. epidermidis produces 186 
antimicrobial peptides which can reportedly control the growth of S. aureus (16) as well as serine 187 
proteases to inhibit biofilm formation (16), fermentation products such as succinic acid that may 188 
inhibit the overgrowth of the opportunistic pathogen C. acnes (46), and a unique form of 189 
lipoteichoic acid that can inhibit skin inflammation during skin injury (57). C. acnes has also a 190 
protective role as a commensal by converting sebum to free fatty acids, which in consequence 191 
inhibit colonisation of opportunistic pathogens and contribute to the maintenance of an acidic skin 192 
pH (46).  193 
In the oral cavity, some streptococci generate hydrogen peroxide that can inhibit the caries-194 
associated bacterium S. mutans (58). The oral microbiome also has non-antimicrobial functions of 195 
importance to health and disease where nitrate-reducing oral bacteria can convert dietary nitrate into 196 
nitrites, which can influence cardiovascular health and blood pressure (59). Nutritional functions of 197 
the oral microbiota are delivered by complex communities via cross feeding and syntrophy. For 198 
example, streptococci have both glycosidic and endopeptidase activity, whilst species of Prevotella 199 
and Porphyromonas species have endopeptidase activity and Fusobacterium and 200 
Peptostreptococcus have aminopeptidase activity (60). Bearing in mind the roles of the skin and 201 
oral microbiome that are currently understood and the fact that other activities remain unknown, the 202 
maintenance and protection of the healthy functionality of the microbiome is an important 203 
consideration when assessing the effect of personal care products.  204 
Microbiome Composition versus function 205 
 206 
Initiatives such as the Human Microbiome Project (HMP) (13) (53) (55) and other studies (14, 52, 207 
61) have enhanced our understanding of baseline skin and oral microbial composition but the search 208 
for attributes that define a healthy human microbiome continues. As part of the HMP, where 200 209 
 9 
healthy individuals were examined, the “core” microbiome of different body sites, including saliva, 210 
plaque, tongue and other oral tissues, ranged from zero to eight operational taxonomic units (OTUs) 211 
when analysed for percentage prevalence of 100% compared to a higher range of 19-75 OTUs when 212 
the percentage was lowered to 50% (62). Interpretation of the core microbiome to measure the 213 
similarity of samples depends on the taxonomic resolution employed since samples may decrease in 214 
apparent similarity when analysed to genus or OTUs compared to phylum level (61) (63) (64). 215 
Whilst a specific group of microorganisms may be shared between individuals, inter-individual 216 
variation may still be considerable at the species-level, and for the presence of rare microorganisms 217 
(8, 14, 61). Care is therefore required when classifying microbiome composition as healthy or 218 
otherwise, especially in the absence of species-level classification. This is of particular importance 219 
in the oral cavity where different species within the same genera can have contrasting associations 220 
between health and disease.  221 
The functions provided by compositionally different microbiomes can be relatively similar between 222 
individuals (55). Exploring which of these general functions are associated with health represents an 223 
alternative to the concept of “healthy composition” (65). A proposed functionality-based definition 224 
of a “healthy microbiome” involves three functions: those associated with health-related 225 
housekeeping functions, human functions, and specialised functions (53). Housekeeping functions 226 
involve energy production and the generation of metabolites and other requirements to maintain the 227 
microbial community itself; human-associated functions comprise interactions with the host such as 228 
developing and influencing the activity of the immune system and specialised functions include 229 
regulation of the pH in a specific body site. A functional core has been described for metabolic 230 
pathways detected in more than 75% of individuals (55). Pathway cores were identified for either 231 
multiple or single body sites, reflecting the fact that some core functions are broadly distributed and 232 
general to the human host whilst others are an adaptation to a specific body site. It should be noted 233 
that core functions are not necessarily beneficial to the host.  Among site-enriched pathways, nitrate 234 
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reduction has been identified as important in the oral cavity (55). These core pathways are generally 235 
associated with microbial consortia. Such functional observations may provide further insights 236 
when studied across populations and during longer temporal studies with a controlled microbial 237 
change. If functional characterisation of the human microbiome can be achieved, measuring or 238 
predicting the loss of a beneficial function or the introduction of an undesired function could be 239 
used as a functional index during consumer safety assurance. 240 
FACTORS THAT CONTRIBUTE TO PERTURBATION OF THE SKIN AND ORAL 241 
MICROBIOME 242 
Microbiome stability as an indicator of health   243 
The stability of the microbiome over time in healthy individuals has been assessed (66). Temporal 244 
stability has been explained as a state of equilibrium for a community regardless of the fact that 245 
some microbes may at the same time be changing as response to disturbances (67). The ability of 246 
the microbiome to remain balanced when exposed to a perturbation and to recover to a healthy 247 
functional profile afterwards has also been proposed as a key feature of a healthy microbiome (53). 248 
Despite their importance for understanding microbial community dynamics and responses to 249 
perturbations, long-term longitudinal studies are still rare. However, based on the available 250 
evidence, the composition of the human microbiome is relatively stable over time, with the main 251 
variation within an individual being between body sites (13) and considerable temporal stability has 252 
also been reported for the microbiome in healthy skin. Oh and colleagues (68) generated 253 
metagenomic sequence data from longitudinal samples collected over 2 years and reported that 254 
bacterial, fungal, and viral communities were largely stable over that time despite exposure to the 255 
external environment. This stability was observed to be site-specific, with body sites harbouring 256 
high microbiome diversity being more variable than low diversity (sebaceous) body sites.  257 
Observations of temporal stability in the skin microbiome have been interpreted as evidence for 258 
colonization resistance and used as the basis for clinical studies exploring skin microbiome in 259 
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disease states, where compositional changes in the microbiome have been reported. Costello et al. 260 
(10) assessed the resilience of the skin microbiota by disinfecting plots on the forehead and left 261 
volar (i.e. underside of) forearms of volunteers and then inoculating them with “foreign” 262 
microbiotas (i.e. taken from the tongue and skin of other individuals). The microbiotas of forearm 263 
plots (n= 16) that had been inoculated with tongue scrapings were more similar to tongue 264 
communities than to those normally associated with the forearm in relative abundance between 2 265 
and 8 h after inoculation. However, communities more similar to those normally associated with the 266 
forehead, developed on forehead plots that had been similarly inoculated with tongue material. It 267 
can be inferred therefore, that for some reason (potentially the presence of sebaceous lipids), the 268 
forehead environment exerted a stronger selection pressure than the forearm. Furthermore, 269 
following interpersonal and inter-gender reciprocal swaps of forehead and forearm microbiotas, 270 
developing communities resembled the recipient rather than the donor, demonstrating the 271 
importance of the environment and possibly, the action of endogenous mechanisms for 272 
individualisation and microbiota perpetuation. The authors hypothesised that the stronger selection 273 
at forehead sites was due to sebaceous secretions which, in contrast to dry sites like the volar 274 
forearm, may have i) been more strongly selective and/or ii) could have supported the more rapid 275 
recolonisation from appendageal structures, which is in agreement with the hypothesis outlined 276 
above.  277 
The oral microbiota may also remain stable over time in healthy individuals (6) although it is also 278 
sufficiently malleable to be beneficially manipulated through hygienic intervention (39). It is 279 
however important to consider what stability means when referring to a host-associated microbiota. 280 
Belstrøm and colleagues collected saliva from five volunteers without oral disease every 4 h for 24 281 
h, repeated this seven days later (69) and profiled the salivary microbiome. Whilst caution is 282 
necessary given the small sample size, the author’s tentative conclusion was that “little or no 283 
variation” within salivary microbiomes was observed over time. The oral cavity is a complex 284 
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environment with various distinct areas, and saliva, often purported to contain microorganisms 285 
originating from multiple sites on the mouth may vary less in terms of microbiome composition 286 
than for example, a tooth surface where in individuals following the recommended oral health 287 
regime of twice daily brushing microbial abundance will be very low immediately after cleaning, 288 
but can exceed 10
7
 bacteria per cm
2
 following regrowth.  289 
Maintaining microbiome stability in healthy individuals will ensure that the beneficial microbial 290 
functions are maintained (70) so the measurement of microbiome stability and its recovery 291 
following disturbance are important in understanding potential risks. Whilst the human microbiome 292 
is relatively stable, its composition can be altered both by pathologies such as gingivitis and 293 
dandruff, or by treatment.  294 
Consumer products can alter microbiome composition or function  295 
The hypothesis that the skin microbiota, once established, is perpetuated by continuous endogenous 296 
inoculation is supported by an investigation by Grice et al. (12) in which skin microbiota was 297 
sampled using swabs and biopsies and profiled by high-throughput sequencing. An attractive 298 
explanation is that secretions from sweat glands and the outward migration of differentiating skin 299 
cells could transport bacteria cells from within appendageal structures continuously onto the skin 300 
surface (as proposed by Kong et al. (71)). Daily hygiene regimens may however affect the 301 
microbiome and some routines tooth brushing and hand washing do this intentionally to 302 
respectively control reduce the risk of oral disease and to reduce the transmission of pathogens, (54, 303 
72). Exposure to antimicrobials through the use of household and personal care products has shown 304 
minimal long-term effects on the microbiome. In this respect, two human studies monitored how the 305 
use of toothpaste, liquid and bar soap, and dishwashing liquid, with and without triclosan perturbed 306 
the microbiome. The first study; a crossover control study involving healthy individuals, showed no 307 
significant impact on human oral or gut microbiome composition during 4 months exposure to the 308 
antibacterial compound triclosan (73). A longitudinal survey of the gut microbiota in infants and 309 
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mothers during the first year following birth also did not show major compositional changes or loss 310 
of microbial diversity (74). It is highly likely that environmental modulation of the skin microbiota 311 
has been occurring since the ancient origins of the microbiome for the skin through UV irradiation, 312 
friction and washing, and for the oral cavity through diet, friction and cleaning. In personal care, 313 
antiperspirants are used by approximately 50% of the global population and have been shown to 314 
reduce bacterial load in the axilla. Individuals that do not use antiperspirants have been observed to 315 
harbour greater axillary microbiome diversity than individuals that use antiperspirants do (75). For 316 
antiperspirant and deodorant users who ceased use of product, an increase in Staphylococcaceae 317 
was observed, in comparison to Corynebacterium species dominating in non-users. Perhaps 318 
surprisingly, microbiome diversity was reported to be greater in antiperspirant users compared to 319 
deodorant or non-users. In a separate study of nine cohorts, axillary diversity was similarly found to 320 
be greater in antiperspirant (and deodorant) users compared to non-users (76). A recent study on 321 
effect of cosmetic products on the microbiome of facial skin of high and low hydration groups 322 
indicated that baseline bacterial diversity was greater in the low than that of high hydration group, 323 
and that the use of cosmetic products  decreased the differences between the two groups (38).  324 
Microbiome individualisation  325 
Evidence suggests that both environment and host genetics play important roles in determining the 326 
composition of individual microbiomes. Salivary microbiome studies in twins indicate that overall 327 
microbial abundance and some aspects of the microbial population structure are influenced by 328 
heritability (77). With respect to the skin microbiome, Blekhman and colleagues (78) analysed 329 
shotgun metagenomic data from the HMP, collecting data on host genetic variation for 93 330 
individuals. They reported significant associations between host genetics and microbiome 331 
composition for ten of the fifteen sites they assessed, including the oral cavity and the skin. Thus, as 332 
well as extrinsic environmental factors, host genetics appears to play a role in the composition of 333 
the oral and skin microbiotas, probably through immunological and other mechanisms. These 334 
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examples partly explain the variability between individuals observed in microbiome research (8) 335 
and highlight the need to separate a significant change from individual variation when assessing 336 
specific perturbations. 337 
Extrinsic factors also influence the stability of the microbiome since activities such as smoking 338 
tobacco have been shown to influence the composition of oral biofilms (79), suggesting that 339 
smoking promotes the acquisition and colonisation of pathogenic bacteria. The development of 340 
gingivitis and its progression from gingivitis to periodontitis and the promotion of dental plaque 341 
biofilm colonisation partly depends on the host immune response (80). Gomez and colleagues (81) 342 
illustrated the impact of host genetics through a human volunteer study involving a large cohort of 343 
monozygotic and dizygotic twin children with and without active caries, with the aim of elucidating 344 
the contributions of host genotype and shared environment on the oral microbiomes (supragingival 345 
plaque) of children. They observed that similarity in oral microbiomes was higher between 346 
monozygotic twins regardless of caries state, with certain taxa being identified as highly heritable 347 
but that most of the variation was determined by the specific growth microenvironment. The caries 348 
state however, was not associated with the more highly heritable bacteria suggesting that lifestyle, 349 
diet and oral hygiene practices might outweigh parental heritability in establishment of a caries 350 
associated microbiome. The more heritable species were detected at lower abundance with 351 
increasing age and sugar consumption.  352 
MEASURING CHANGES IN MICROBIOME COMPOSITION AND ACTIVITIES 353 
 354 
Risks of pathogen colonisation 355 
One of the beneficial activities of the microbiotas of the skin and oral cavity is the protection of the 356 
host tissue from pathogens (as summarised in Figure 1). Perturbation of commensal communities 357 
may be therefore a contributing factor to the pathogenesis of certain inflammatory conditions. In 358 
some circumstances, overgrowth of commensal microorganisms with pathogenic potential 359 
(pathobionts) or colonisation by external pathogenic organisms (transients) can cause disease. The 360 
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ability of transient organisms to colonise is likely to depend on the interactions with the 361 
commensals residing at each specific body site. In this respect, microbial communities with more 362 
competitive interactions than cooperative interactions are assumed to be more resilient in the sense 363 
that cooperation causes coupling between species involving several species to change at the same 364 
time and destabilise the system (82). In the mouth, loss of colonisation resistance through antibiotic 365 
use can lead to infections by opportunistic pathogens such as Candida species and S. aureus (as 366 
reviewed (83) (60)). In this regard, microbial changes that do not increase the opportunity for 367 
pathogens to colonise are unlikely to adversely affect the wellbeing of the host. 368 
The human body as a microbial niche 369 
The skin and oral cavity present distinct environments, and ecological conditions in situ, have a 370 
large influence on the compositional differences in microbiota between body sites. Oily, moist and 371 
dry skin sites regulate nutrients and harbour specific microbial taxa (46, 52, 84). The mouth can be 372 
broadly divided into different habitats: the gingiva and hard palate; the tongue and throat; and 373 
dental plaque; each one colonised by a microbiome characteristic of the specific site (60). The 374 
microbiota present in the oral cavity form biofilms by attaching to the different surfaces, which 375 
confer spatial structure and provide the conditions required for different organisms to survive within 376 
the community (85). The availability of oxygen is one of the drivers of microbiota composition and 377 
in this context, a succession during the formation of dental plaque has been proposed whereby teeth 378 
are initially colonised by facultative genera such as Streptococcus, with a shift to a microbial 379 
community better adapted to anaerobic conditions, as the biofilm matures. Bacterial succession on 380 
the tooth surface can also be strongly influenced by nutrient availability, mechanical stress and 381 
saliva flow (6, 61, 86) and by binding of bacteria to proteins in the salivary pellicle coating the tooth 382 
surface (87). 383 
Interactions with the external environment can also drive selection. For example, an increase in 384 
sugar intake or a reduction in saliva flow may induce a reduction in pH that allows the expansion of 385 
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aciduric organisms (86). Loss of moisture, changes in temperature and exposure to ultraviolet 386 
radiation can also result in microbiota alteration in the skin (88). Similarly, changes in the spatial 387 
structure may also influence the microbial community within a given body site (9, 88).  388 
 389 
Microbial diversity in health 390 
Several indices have been employed to differentiate microbiomes associated with health and 391 
disease. Among these, microbial (ecological) diversity is frequently measured. Ecological diversity 392 
can be measured as richness (the number of taxa present) and evenness (the abundance of microbial 393 
constituents). Although not universally applicable, higher diversity has been associated with health 394 
in specific contexts when considering that more diverse microbes may supply the host with 395 
increased functional traits. However, microbial diversity on its own is not an accurate measure for 396 
determining disease aetiology or health. Whilst reduced microbial diversity has frequently been 397 
observed in conditions such as atopic dermatitis and psoriasis (89)-(90) this is not always the case, 398 
for example, in both psoriatic and unaffected elbows (81) richness has been reported to be the same 399 
whilst, an increase in bacterial diversity due to the rise of species of minor abundance has been 400 
observed in gingivitis and periodontitis (64, 91). The measurement of diversity also does not 401 
account for interactions among species and two microbiomes with the same level of diversity may 402 
be different. It may therefore be more pertinent to observe the entire community of microbes 403 
present and by extension how they are functioning, rather than relying on richness alone as a 404 
predictor of disease (92). 405 
The importance of bacterial abundance 406 
Compositional studies of the skin and oral microbiomes have suggested that the load or abundance 407 
of organisms can be more significant than their presence in the progression of disease. A 65% 408 
increase in the proportion of S. aureus in atopic dermatitis sufferers at flare sites and partial 409 
correlation between S. aureus abundance and disease severity have been reported (99). Similarly, S. 410 
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epidermidis was significantly more abundant during flares than post flares and in controls, although 411 
the underlying reasoning for the increase in S. epidermidis was not determined (99).  Several studies 412 
have reported increased C. acnes abundance in acne compared to unaffected volunteers (93). Whilst 413 
differences between the absolute numbers of bacteria between inflammatory acne, papules and 414 
pustules have been reported there appears to be progressively higher bacterial loads vis-à-vis 415 
severity of the disease (94). The use of quantification methods such as quantitative PCR has 416 
revealed higher levels of S. mutans and S. sobrinus in children with caries compared to caries-free 417 
children (95). In other oral diseases such as gingivitis, severity is better correlated with the plaque 418 
load and maturity than with some specific bacteria (60). It should however be born in mind that 419 
NGS is not well-suited to determining differences in bacterial absolute abundance (quantified 420 
genetic or microbial load within a sample) such that two samples with identical relative abundance 421 
(genetic representation of microbes within a sample ranked against all taxa in the sample) could 422 
differ markedly in absolute abundance (96). 423 
Host-microbiota interactions 424 
Skin functions as a two-way barrier, which helps to preserve hydration levels and prevent entry of 425 
noxious substances into the body. Skin function may be shaped by the commensal organisms and in 426 
this respect, Naik et al. (97) demonstrated that germ-free mice had a weakened immune response to 427 
the parasite Leishmania major compared to mice raised under specific pathogen-free conditions. 428 
The impaired response in the germ-free mice could be rescued by colonisation with S. epidermidis 429 
(97) implying a role for the microbiota in promoting host immunity. More recent evidence suggests 430 
that the microbiota is fundamental to skin structure. Conventionally reared mice showed altered 431 
gene expression compared with germ-free mice. Meisel et al. (98) reported that 2820 genes were 432 
differentially regulated by microbial colonisation, which included genes associated not only with 433 
the host immune response but also epidermal differentiation. Crucially, the expression of 9 genes 434 
involved in the epidermal differentiation complex (EDC), a collection of genes involved in terminal 435 
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differentiation of keratinocytes (reviewed in (99)), was regulated by the microbiota. When the skin 436 
of conventionally raised mice was compared to germ-free mice, differences in the balance of 437 
proliferation and differentiation were observed. These data support the view that the microbiome 438 
may be associated with the development of the skin architecture since the EDC has been implicated 439 
in dermatological diseases such as psoriasis (reviewed in (100)). Various studies have shown that 440 
the microbiota is associated with the outcome of the healing response when wounding breaches the 441 
skin barrier. In broken skin the commensal microorganisms can behave as pathogens and 442 
colonisation of wound sites can result in release of microbial metabolites that can further damage 443 
host tissues (reviewed in (101)). It is therefore unsurprising that accelerated wound healing has been 444 
observed in the absence of microbiota (102, 103) but it is also the case that the commensal 445 
microbiota can produce antimicrobial peptides (AMPs) that can inhibit the invasion of wound sites 446 
by pathogens (104). There is also evidence that S. epidermidis can inhibit the uncontrolled 447 
inflammation sometimes associated with wounding. Part of the mechanism for this may involve the 448 
inhibition of cytokine release by keratinocytes (57).  449 
With respect to beneficial effects, S. epidermidis has been reported to augment tight junction 450 
function in keratinocytes (105) where the interaction of keratinocyte monolayers with S. 451 
epidermidis increased the trans-epithelial electrical resistance (a measure of tight junction function) 452 
within a short time of exposure to this bacterium. Furthermore, toll-like receptor (TLR) ligands such 453 
as lipoteichoic acid or peptidoglycan may augment tight junction function in keratinocyte 454 
monolayers (106). These data suggest that skin commensals, like those of the gut, are probably 455 
involved in many aspects of epithelial barrier homeostasis.  456 
MEASURING CHANGES IN MICROBIOME COMPOSITION  457 
Various data analysis methods are used in microbiome research that can objectively assess 458 
microbial changes. This section describes the information that each technique provides and how it is 459 
applied to characterise health and disease. 460 
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Metagenomic profiling  461 
Studies employing both ribosomal profiling and metagenomics have sought to identify microbes 462 
linked to either oral or cutaneous disease, whether at the community level or that of individual taxa. 463 
Several studies have reported changes in the proportion of bacteria on the skin in psoriasis (25, 26, 464 
89). Gao et al (25, 26) for example reported that Firmicutes were significantly overrepresented in 465 
psoriasis lesions compared to uninvolved skin, whilst the Actinobacteria and Propionibacterium 466 
species were reportedly present at significantly lower relative abundance in psoriatic lesions. Apart 467 
from bacteria, the fungal genus Malassezia has also been associated with psoriasis (89, 107-110). 468 
Altered microbial community profiles have also been reported in atopic dermatitis, where an 469 
increased proportion of Staphylococcus, particularly S. aureus and S. epidermidis, were observed 470 
during disease flares in comparison to baseline or post-treatment, and correlated with increased 471 
disease severity (111-113).  472 
In terms of the oral microbiota, changes in microbial composition have long been associated with 473 
dental caries and periodontitis. For caries, sequence analysis has confirmed that bacteria other than 474 
S. mutans are correlated with active caries (Lactobacillus and Bifidobacterium) and likewise several 475 
taxonomic groups of bacteria are associated with periodontitis (28, 114-117). It is also clear that the 476 
aetiology of disease also involves a complex interplay between the host and the resident microbial 477 
communities that is yet to be fully explored. Applied to the study of psoriasis, such approaches 478 
indicate that strain level features and associated functional variation may be pertinent to disease 479 
(118). 480 
This exploration of host-microbe interactions have been hindered by the fact that virulence and 481 
pathogenic determinants could be partitioned at the sub-species or strain level. It is well established 482 
that intra-species genomic features lead to phenotypic variability (113, 119-121). Ribosomal 483 
genera-based profiling approaches lack strain level resolution. Several recent computational tools to 484 
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taxonomically (122-124) and functionally (125, 126) characterise individual members of the 485 
microbiome at strain level resolution in metagenomic datasets have become available.  486 
Profiling of functional potential 487 
Whilst understanding the community structure of a microbiome and the relationship between 488 
specific taxa and health or disease can be informative, knowledge of community function will 489 
probably be most useful in understanding the effect of perturbing the microbiome. Shotgun 490 
metagenomics provides the potential to access strain level taxonomic features and the potential 491 
functional characteristics of the community which has until recently been computationally 492 
challenging. This approach can be used for the investigation of functional traits, although it can 493 
only reveal the functional potential of communities. It can also be used to profile viruses, which are 494 
not amenable to ribosomal-based profiling. The oral microbiome have assessed disease states such 495 
as caries or periodontal disease compared to healthy controls. Shi et al. (127) and Wang et al. (128) 496 
reported that community function around bacterial chemotaxis and cell motility are increased in 497 
disease compared to periodontal health. It has also been shown that in periodontal disease there is 498 
an increase in metabolic pathway genes associated with fatty acid metabolism (129), as well as an 499 
increase in genes associated with the metabolic degradation of nutrients (127) and those required for 500 
growth in anaerobic conditions (129). Healthy communities have been shown to exhibit increased 501 
functions in the areas of fatty acid biosynthesis, aspartate and homoserine metabolism, membrane 502 
transport and signal transduction. Metagenomic studies of the skin are more difficult due to the low 503 
bacterial density and small sample surfaces available (130). Mathieu et al. (131) consider the skin 504 
microbiota as a complete organism, reporting a predominance of catabolic genes and the ability of 505 
the skin bacteria to use the sugars, lipids and iron that are found on human skin. They also found 506 
genes related to antibiotic resistance, as well as some linked to acid resistance, clearly a mechanism 507 
for tolerance of the natural acidity of the skin. Oh et al. (17) have described a “functional core” of 508 
around 30% of the community that can vary depending on the diversity and biogeography of the 509 
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differing skin microenvironments, which drives the functional capacity that is required by that 510 
community. For example, dry sites were found to favour functional traits surrounding the citrate 511 
cycle, and sebaceous sites showed increased function around glycolysis and ATP/GTP/NADH 512 
dehydrogenase I.  Whilst these metagenomic approaches exceed a simple inventory of taxa and 513 
provide information on function and health/disease interrelationships, making judgements of 514 
community functional traits by reference genome comparison should be undertaken with care. 515 
There is a large genomic diversity that is just starting to be understood, for example the association 516 
of only some C. acnes strains with acne vulgaris (123) (130). Further complicating the search for a 517 
functional understanding of the microbiome is the identification of new genes from metagenomic 518 
analysis approaches that are associated with health or disease, but which cannot be assigned to any 519 
functional pathway.  520 
Metatranscriptomic analyses 521 
Shotgun transcriptomics can be used to determine the active functions of a microbiome (132), 522 
especially as the community composition of a microbiome alone is not necessarily reflective of its 523 
active community members (133). This is an emerging research area with less data available, and 524 
challenges remain, for example in sampling sufficient mRNA material to enable analysis. However, 525 
the transcriptomic profile of a community is dynamic and can easily change in the same biological 526 
sample at different times as the microbiome responds continually to changing environmental and 527 
host conditions. Metatranscriptomic studies applied to human microbiome are more limited in 528 
comparison to metataxonomic/metagenomics surveys.  529 
In comparison to the oral microbiome, metatranscriptomics of the skin is more challenging due to 530 
the limitations of microbial biomass in the sample material. Kang and colleagues (132) analysed the 531 
metatranscriptomics of patients with acne vulgaris versus healthy controls. C. acnes was reportedly 532 
the most transcriptionally active organism and was predominant in both the healthy and diseased 533 
samples. Further analysis of the gene expression profile of C. acnes in the samples identified that 534 
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the organism’s activity on acne-affected skin was distinct from its activity on healthy skin. 535 
Specifically, vitamin B12 biosynthesis pathway was observed to be significantly downregulated in 536 
acne. Additionally, a model of how vitamin B12 modulates the transcriptional and metabolic 537 
activities of C. acnes in acne pathogenesis was suggested. The model underlined how shotgun 538 
metatranscriptomic approaches can enhance the understanding of disease pathogenesis. One of the 539 
limitations of meta-transcriptome data is the final metabolic products generated by a microbial 540 
community are not captured (133). In this respect, techniques such as proteomics, metabolomics, 541 
and lipidomics can help to have a deeper functional characterisation of the microbiome. 542 
Metatranscriptomics has been used in conjunction with metagenomics to investigate saliva from 543 
individuals with caries and periodontitis to compare with saliva from orally disease-free individuals. 544 
Belstrom et al. (69) identified 15 differentially expressed KEGG Orthologs (KOs) between 545 
periodontitis or caries samples when compared with orally healthy controls. These included eight 546 
carbohydrate metabolism-associated KOs that were downregulated in periodontal disease and two 547 
KOs that were upregulated in caries associated with glycan biosynthesis and carbohydrate 548 
metabolism. In addition, the same study observed that lipid metabolism was increased in healthy 549 
samples when compared with dental caries and concluded that longitudinal studies may reveal that 550 
screening salivary metabolic gene expression can identify oral diseases preclinically. However, it is 551 
also clear that development of such diagnostics is at a very early stage and that overcoming the very 552 
significant differences in complexity between the salivary and plaque microbiomes would be a 553 
substantial technical and clinical challenge.  554 
Metabolomic analyses 555 
Microbial metabolites can have a direct impact on oral or skin health (e.g. short chain fatty acids 556 
and sulphides in periodontal diseases, organic acids in dental caries) or they can enter and modulate 557 
host metabolic processes. As such, metabolite exchange between the microbiome and host 558 
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represents one mechanism through which these systems communicate. Variation in the bacterial 559 
species present can modulate the genetic library of the microbiome, changing its overall functional 560 
capacity, its metabolite production, and the downstream impact on host health. However, different 561 
species are known to possess similar or even the same metabolic traits. This functional redundancy 562 
means that studying composition alone may be insufficient to accurately determine the overall 563 
biotransformation capabilities of the microbiome and therefore its potential to modify host health. 564 
Metabolic profiling (metabolomics/metabonomics) has emerged as a powerful tool for studying the 565 
microbiota because it can ascertain the metabolic profile via low molecular weight compounds in a 566 
sample. These metabolic signatures contain thousands of molecular small molecular weight 567 
compounds reflecting biochemical events. This includes host metabolic processes but also those 568 
performed by the resident microbes and products arising from interactions between the two. Studies 569 
using metabolomics to directly assess the functional status of the skin microbiota are limited. 570 
However, several studies have characterised the skin metabolome in a wider context. These have 571 
used a variety of sample types including skin swabs, hydrogel micropatches (134), punch biopsies 572 
and sweat. In one study analysing epidermal skin tissue, several bacterial-derived metabolites (135) 573 
and bacterial substrates were observed, including p-cresol, a bacterial metabolite of tyrosine. This 574 
demonstrates that these tissue samples can be informative for studying the skin microbiome. Skin 575 
surface liquid extracts (sweat) represent another sample type of potential utility. These are complex 576 
mixtures of secretions derived from eccrine, apocrine and/or sebaceous glands  (depending of body 577 
location) as well as from the microbiota inhabiting the skin (136). Attempts are being made to 578 
optimise and standardise the collection and analysis of sweat and this may prove to be a useful 579 
resource for studying the skin microbiota.  580 
Metabolic profiling of gingival crevicular fluid (GCF) has been used to study the importance of 581 
host-bacterial interactions in periodontal disease. Here, the depletion of anti-oxidants, degradation 582 
of host cellular components and accumulation of bacterial products were seen in the disease state 583 
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(137) (138). Attempts have been made to integrate salivary bacterial and metabolic datasets to 584 
identify metabolic products related to specific bacterial groups (139). Oral biofilms have also been 585 
studied by capillary electrophoresis-mass spectrometry (CE-MS)-based metabolomics. This has 586 
enabled the central carbon metabolic pathways to be investigated in the oral biofilm. One approach 587 
is to measure these pathways in supragingival plaque before and after a glucose rinse.  Glucose can 588 
be degraded by bacteria to several metabolic products, including acetate, formate, lactate, and 589 
succinate. Assessing the metabolic content of this plaque after the rinse provides information on the 590 
functional capacity of the biofilm.  591 
Mathematical modelling  592 
Oral and skin microbial community dynamics are shaped by three broad factors: the host, the 593 
environment and the community. The human host provides the microenvironment for the 594 
community and may alter this environment through hygiene and other behaviours. The genetic 595 
makeup of the host also influences the community's microenvironment. The surrounding 596 
environment offers a large species pool from which immigration into the local community may take 597 
place. Finally, community composition (richness, evenness and interactions) as well as history (e.g. 598 
previous exposure to perturbations) may impact its dynamics. 599 
A community model expresses in mathematical terms how selected factors influence community 600 
dynamics. Community models thus allow prediction of the response of the community to short-term 601 
(pulse) perturbations and altered conditions (press perturbations). Models can be coarse-grained or 602 
detailed, describing populations or individuals. A general distinction can be made between 603 
phenomenological models that predict community behaviour on the basis of immigration and 604 
mortality rates, interaction strengths, growth rates and other parameters, and metabolic models that 605 
take underlying molecular mechanisms of interactions into account. The generalized Lotka-Volterra 606 
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equation and its variants (140-142), but also individual-based models such as the neutral model 607 
(143) and its extensions are examples of the former.  608 
In the oral cavity, these models have to deal with the complication that most community members 609 
can exist in both a free-floating planktonic state, as well as part of a biofilm, which may have 610 
different growth rates, different access to nutrients and engage in different interactions. Previously, 611 
Schroeder and colleagues (144) proposed a discrete and continuous version of a model that 612 
describes the dynamics of both planktonic and sessile communities in drinking water pipes and 613 
which may be adapted to model community dynamics in the oral cavity. The programming 614 
language “gro”, which was designed for individual-based modelling of spatially structured 615 
microbial communities, may also be of interest in this respect (145). This facilitates the modelling 616 
of cell behaviours planktonically or in microcolonies or biofilms. A range of factors including 617 
growth rates, cell-signalling, diffusing and chemotaxis can be factored in.  618 
Metabolic models require the accurate reconstruction of each community member's metabolism 619 
(146), which is a major hurdle because of lack of reliable and complete genome annotations and the 620 
large percentage of unknown gene functions.  Metabolic reconstructions may be quickly generated 621 
automatically with tools such as ModelSEED or RAVEN (147) (148). This type of modelling 622 
present some disadvantages such as the requirement for a tedious manual curation to ensure an 623 
accurate reconstruction (149) and the assumption that community members are in a metabolic 624 
steady state. This assumption is relaxed by some dynamic metabolic models which require kinetic 625 
parameters such as compound uptake rates (146). The dynamic individual-based metabolic 626 
modelling tools COMETS (150) and BacArena (151) additionally take spatial structure into 627 
account, which is important to model biofilms. Metabolic models can also integrate meta-omics 628 
data as additional constraints on metabolic fluxes (152). For example, gene expression data has 629 
been used to validate metabolic models (153). Despite their promise, to the best of our knowledge, 630 
metabolic models have only been applied to communities consisting of a small number of species. 631 
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Metabolic models of species grown alone and in pairs can be exploited to predict ecological 632 
interactions (154). For instance, gut microbial interactions were predicted based on the semi-curated 633 
reconstruction of 773 gut species (155). The extension of dynamic and spatial metabolic models to 634 
more complex microbial communities is a promising field for future research.  635 
Community-level metabolic networks are a simpler form of metabolic models, where metabolites 636 
and reactions are represented as nodes and edges, respectively, but where stoichiometric 637 
coefficients are not taken into account (156). They offer a framework for the straightforward 638 
integration of meta-omics data as node or edge weights (157). While metabolic networks can handle 639 
larger communities, they do not allow quantitative modelling (158).  640 
Quantitative community models have parameters, which need to be determined through 641 
measurements in well-controlled conditions. For instance, growth assays in mono- and co-culture 642 
can provide growth rates and interaction strengths.  Once a model is parameterized, it needs to be 643 
validated experimentally. Such a validation consists of comparing the outcomes of experimental 644 
perturbations with the outcomes predicted by the model. The model may undergo several rounds of 645 
adjustment and validation until it reaches sufficient accuracy, or it may fail to be predictive because 646 
important but unknown factors are not taken into account or the community dynamics are chaotic or 647 
predominantly stochastic. A model that predicts community dynamics to an acceptable level of 648 
accuracy can be applied to simulate the effects of yet untested perturbations on the community. 649 
 650 
CONCLUSIONS 651 
Perturbations of the microbiome can have positive and negative consequences for human health. 652 
However, more knowledge is required to understand the extent of change that corresponds to the 653 
maintenance of health and the establishment of disease states. Microbiome research is still in its 654 
early stages and further studies to elucidate the nature of the functional and structural interactions 655 
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among microorganisms and with the host are required. Analysis of the gut microbiome is advancing 656 
faster than that of the skin and oral microbiomes, where increasing research investment would help 657 
to understand better the dynamics of those two specific body niches. Although mankind has been 658 
manipulating its microbiome, often beneficially, through diet, hand washing and oral hygiene 659 
practices both modern and historic, for hundreds if not thousands of years, the risks of manipulating 660 
the microbiome through new technology innovation should be properly assessed and the 661 
development of appropriate methods is required. Numerous factors should be considered when 662 
assessing the safety of novel approaches to microbiome perturbation, and approaches need to be 663 
developed to ensure that a compositional change delivers benefits whilst not compromising the 664 
stability, diversity and immunological state required for healthy functionality of the microbiome. 665 
These are summarised in Table 1 and Figure 1. To increase our understanding of the safety of 666 
microbiome changes, multi-disciplinary research needs to move to a mechanistic understanding to 667 
allow measurable elements specific to the oral and skin microbiome to be identified.  668 
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TABLE 1. Habitat parameters, microbiome functions and intervention strategies for human skin and oral cavity  1296 
 
Skin Oral cavity 
Conditions with 
microbiome 
associations 
Atopic 
dermatitis, 
psoriasis 
Acne Dandruff Axillary 
malodor 
Caries Gingivitis Periodontitis 
Routine 
perturbations 
Cleansing, 
moisturizing, 
use of cream, 
gels, lotions 
Cleansing, use 
of cream, gels, 
lotions 
Cleansing, use 
of shampoo 
Cleansing, use 
of 
antiperspirants 
and deodorants 
Toothbrushing, flossing, use of toothpaste, mouthwash 
Microbiome 
understanding and 
potential target 
mode of action for 
microbial 
interventions 
S. aureus load 
correlates with 
atopic 
dermatitis 
flares (18) 
Early 
colonization 
with 
commensal 
staphylococci 
provides 
protection 
(REF 18, 19) 
Abnormal 
expression of 
antimicrobial 
peptides (22) 
Changes in the 
proportion of 
bacteria 
Outgrowth of C. 
acnes and 
overproduction 
of sebum 
associated to 
acne (21, 93) 
Associated with 
specific strains 
of C. acnes (42, 
119, 129) 
Decrease in the 
Vitamin B12 
biosynthesis 
pathway (132) 
 
Associated with 
an imbalance of 
both bacterial 
and fungal 
species, with an 
increase in 
Staphylococcus 
sp. and M. 
restricta (40). 
Severity of 
dandruff 
dependent on 
the interactions 
between the host 
and 
microorganisms 
(43) 
Decreased 
Propionibacteri
um and 
increased 
Associated 
with 
Corynebactriu
m species (44) 
Malodour 
caused by 
short and 
medium chain 
volatile fatty 
acids (44) 
Changes in oral 
microbiota 
composition  
(28, 29) 
 
Outgrowth of acid-
tolerant 
Streptococcus 
mutans (30), S. 
sobrinus (96), 
Lactobacillus and 
Bifidobacterium 
(28, 114-117) 
Increased glycan 
synthesis and 
carbohydrate 
metabolism and 
reduced lipid 
metabolism (69) 
 
Changes in oral 
microbiota 
composition  
(28, 29) 
 
Subversion of 
host response at 
inflamed site, 
colonization of 
inflamed tissue by 
Porphyromonas 
gingivalis (33) 
Plaque load and 
maturity (60) 
 
 
Changes in oral 
microbiota 
composition (28, 29) 
Sub-gingival biofilm 
formation is 
associated with 
inflammation and 
bone loss (31) 
Translocation of oral 
microbiome to 
systemic circulation 
(34-36) 
 
Increased metabolic 
degradation of 
nutrients and fatty 
acid metabolism 
(126, 128) 
Increased gene 
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compared to 
healthy skin 
(25, 26) 
Associated to 
the fungus 
Malassezia 
(106) 
Staphylococcus 
abundance (43) 
 
 activity related to 
anaerobic growth 
conditions (128) 
Depletion of anti-
oxidants, degradation 
of host cellular 
components and 
accumulation of 
bacterial products 
(136, 137) 
Ecological factors 
specific to the 
human body site 
Bacteriocins and phenol soluble modulins contribute 
to the maintenance of the niche (56) 
Skin has a mixture of secretions from different 
glands and microbiota (137) 
Host physiological conditions such as sebum and 
water content are relevant in scalp (43)  
Higher exposure to moisture, changes in temperature 
and UV (88) 
Host factors including skin barrier protein mutations 
e.g. Filaggrin in AD (20) and mTORC1 changes 
(increase sebum formation) due, in part, to diet (21)  
Host immune/inflammatory status (23 - 27) 
Food intake, high intake of sugar correlated to production of lactic acid and 
acidification (REF 30,31) 
Biofilm formation by attaching to different surfaces (30, 31) 
Host susceptibility (32) 
Presence or absence of inflammation (33) 
Oxygen availability, mechanical stress and saliva flow (6, 61, 86) 
 
Antibiotic use (60) 
 
Exposure to tobacco smoke (79) 
Selected microbiota 
functions  
S. epidermis produces AMPs to control the growth 
of S. aureus (16), serine proteases to inhibit biofilm 
(16) and fermentation products to inhibit C. acnes 
(46) 
C. acnes converts sebum to free fatty acids, inhibit 
colonisation and maintains acidic pH of the skin 
(46) 
Some streptococci generate hydrogen peroxide to inhibit S. mutans (58) 
Nitrate-reducing bacteria can influence cardiovascular health and blood pressure 
(59) 
Some streptococci support enzymatic reactions for nutritional purposes (60) 
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FIG 1. Assessing the safety of perturbations of the skin and oral microbiome1298 
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